Skip to main content
. 2019 Mar 12;10:205. doi: 10.3389/fneur.2019.00205

Figure 4.

Figure 4

Patients suffering from progressive forms of MS show lower levels of sICAM-5 in CSF. (A) ICAM-5 concentration in ng/ml in the cerebrospinal fluid of NIND patients (NIND, n = 35), RRMS (n = 17), PPMS (n = 19), and SPMS (n = 12) patients. Data shown are mean ± SEM. One-way ANOVA followed by Tukey's multiple comparison test, *p < 0.05. (B) Correlation between EDSS or disease duration in months and ICAM-5 concentration in CSF (ng/ml). Data was tested for normality using Shapiro-Wilk normality test and Pearson's or Spearman's r and p-values were determined accordingly.